Introduction
============

Asthma is a chronic inflammatory disease of the airways characterized by infiltration and activation of inflammatory cells and by structural changes, including subepithelial fibrosis, smooth muscle cell hypertrophy/hyperplasia, epithelial cell metaplasia, and angiogenesis. These structural changes are believed to correlate with the severity of asthma and to some extent with the development of progressive lung function deterioration. The mechanism underlying airway angiogenesis in asthma and its precise clinical relevance has not yet been completely elucidated.[@b1-jaa-3-177]

Asthma may best be described as a loosely defined syndrome characterized by respiratory symptoms, airways narrowing, and inflammation. Asthma is a common pulmonary condition that involves heightened bronchial hyperresponsiveness and reversible bronchoconstriction, together with acute-on-chronic inflammation that leads to airways remodeling. The most common causes predisposing for asthma include viral upper respiratory tract infections, cigarette smoke, cold temperatures, allergies, pets, and exercise. Symptoms of asthma include wheezing, intercostal and supraclavicular retraction, cough (worse at night), shortness of breath, chest pain, exercise intolerance, and limitation of daily activities, which should alert physicians to a diagnosis of possible asthma or an asthma exacerbation.[@b2-jaa-3-177],[@b3-jaa-3-177]

Allergic asthma is characterized by a specific pattern of inflammatory attributes driven by IgE-dependent triggering of resident tissue mast cells and characterized by the influx of basophils and eosinophils in inflamed airways. The interaction between inflammatory cells and structural cells in asthmatic airways is complex. Several cytokines and growth factors released during allergic airway inflammation and remodeling are responsible for increasing basal levels of vascular endothelial growth factor in fibroblasts and smooth muscle cells.[@b1-jaa-3-177],[@b4-jaa-3-177],[@b5-jaa-3-177]

In spite of its great burden on public health care, our knowledge of the etiologic mechanisms underlying asthma, both genetic and environmental, is still very limited. One of the most promising approaches to expand further our understanding of the disease mechanisms involved is identification of the genetic variation that contributes to the risk of developing asthma.[@b6-jaa-3-177]

In recent years, research has mainly focused on detecting the genetic variations that predispose the individual to asthma. Three basic types of genetic study have been undertaken, ie, genetic linkage analysis, searches for focused candidate genes, and the modern genome-wide association studies performed with single nucleotide polymorphism (SNP) chips. Extensive epidemiologic studies have made little progress in determining the individual's susceptibility to asthma. The molecular genetic studies of asthma offer the prospect of defining this susceptibility at a genetic level, and allow more precise studies on the etiology of asthma to be undertaken.[@b7-jaa-3-177]--[@b9-jaa-3-177]

Family studies using linkage methodologies conducted to date have not been very successful in identifying the genetic determinants of this complex disease.[@b10-jaa-3-177] The revolution in genotyping technology with high-throughput methods now allows genotyping of greater numbers of SNPs in large cohort genome-wide association studies. Most of the genes uncovered during recent years with the genome-wide approach are novel, and were not even considered in the old candidate gene studies. Asthma is an example of a complex disease where several common susceptibility alleles affect the disease risk in varying combinations, but in a manner such that each gene contributes only a minor impact.[@b11-jaa-3-177] The downstream biologic effects of the majority of these genes and their proteins are still unknown. Expression studies of these genes and proteins could allow us to uncover some of their effects.[@b12-jaa-3-177]

If some of the unexplained heritability in genome-wide association studies was due to interactions then, rather than discovering interactions per se, one goal might be to use these interactions in order to discover novel genes that act synergistically with other factors without having demonstrable marginal effects.[@b13-jaa-3-177]

Materials and methods
=====================

Literature search
-----------------

A literature search in PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>) was carried out in September 2009 with the search phrase "asthma and SNP". The list obtained was then manually annotated, and a list of SNP modifications in asthma was collected. Even though this is probably not a complete list, it gives a very good idea of the found and proposed SNP modifications linked to asthma. The list of SNPs claimed to be associated with asthma ([Table 1](#t1-jaa-3-177){ref-type="table"}) was used for further analyses.

Protein--protein interaction networks
-------------------------------------

We used a web-based protein interaction network analysis platform (PINA), which integrates protein--protein interaction data from six databases. The Cytoscape757 program provides a network construction tool, which uses our protein--protein interaction data as the baseline. The SwissProt names without the tag "\_\_HUMAN" are used throughout this study, if not otherwise stated.

The gene ontology categories provide a controlled vocabulary to describe the gene and the gene product attributes of any organism. The enrichment analysis of proteins in the various gene ontology (GO Slim) categories was carried out essentially as described elsewhere.[@b14-jaa-3-177]--[@b16-jaa-3-177]

When the analysis within these annotated categories was carried out, we searched for enriched categories. The basic question was: Is the category "toll-like receptors" or the key phrase "cytokine--cytokine receptor interaction" within the observed SNP-related network enriched when compared with the background set of the whole human proteome? If such a phenomenon was observed, it could suggest that these enriched categories and keywords play a role within the SNP-related protein network found in asthma patients.

Results
=======

We first searched the literature published for 2000--2009 on the association of SNPs with asthma. The search produced 251 articles, from which a list of 127 genes and their corresponding proteins linked to asthma was compiled ([Table 1](#t1-jaa-3-177){ref-type="table"}). Next, we generated a protein--protein interaction network for these 127 proteins. The interacting protein partners for each of these proteins were searched with PINA, which integrates six different protein--protein interaction databanks.[@b17-jaa-3-177]

We first pulled down all the protein--protein interactions of these putatively asthma-related proteins, which resulted in a very large network with 1073 proteins (nodes) and 1421 connections (edges) between them. This large data set was imported to Cytoscape and the network is displayed in [Figure 1A](#f1-jaa-3-177){ref-type="fig"}.[@b18-jaa-3-177] In order to facilitate data mining within the protein--protein interaction network, we created a more stringent query yielding a smaller subset of the original large network. This new limited network contained interacting proteins which were bound to at least two other proteins identified to carry asthma-related SNP modifications in their corresponding genes. This data set contained only 309 proteins (96 of which were SNP-related proteins, 213 interacting proteins, and 644 connections between them, [Figure 1B](#f1-jaa-3-177){ref-type="fig"}).

Because such a network is far too large to be analyzed visually in a meaningful manner, we decided to perform a gene ontology enrichment analysis. When the analysis within the gene ontology-molecular function categories was performed, several strongly enriched classes were observed, as shown in [Table 2](#t2-jaa-3-177){ref-type="table"}. "Protein binding" and several of its daughter categories, including receptor binding, cytokine binding, growth factor binding, interleukin binding, transcription factor binding, chemokine binding, and pattern binding, were among the most significantly enriched categories. Furthermore, protein kinase activity, including tyrosine and serine/threonine kinase activity, as well as endopeptidase activity, was significantly enriched within the asthma-related SNP-modified genes and their corresponding proteins.

To utilize this asthma-related network further, we searched for connections between the asthma-related SNP proteins only ([Figure 2](#f2-jaa-3-177){ref-type="fig"}). The results showed that while 31 of the 96 proteins do not interact with any other SNP protein, 14 interact with each other, 20 form a pair, two triplets, one a quartet, and two larger networks contain several connected asthma-related SNP proteins. The chemokine network includes eight proteins and the toll-like receptor network 13 proteins, all shown to carry asthma-related SNP modifications among their corresponding genes. We expanded to the most interesting networks with PINA and were able to create two new networks in Cytoscape. The chemokine network (green proteins, [Figure 3](#f3-jaa-3-177){ref-type="fig"}) shows eight asthma-related SNP proteins binding to each other. Furthermore, a great number of other chemokines and their receptors also show an interaction within this network (yellow proteins, [Figure 3](#f3-jaa-3-177){ref-type="fig"}).

Likewise, the other new subnetwork displays 13 asthma-related SNP proteins interacting with each other ([Figure 4](#f4-jaa-3-177){ref-type="fig"}). This toll-like receptor/cytokine network also contains a large group of novel proteins, including toll-like receptors and cytokines, as well as signal transduction molecules (yellow proteins, [Figure 4](#f4-jaa-3-177){ref-type="fig"}). Such an enlarged network of interacting proteins could putatively be used to search for novel proteins having a crucial role in the development of asthma-related inflammatory reactions. Of great interest are the nonsynonymous SNPs, which code for an alternative amino acid sequence of proteins. The red proteins within [Figure 4](#f4-jaa-3-177){ref-type="fig"}, ie, TLR1, TLR4, TLR5, TLR6, TLR10, and IL4R and IL13, are among these. This small subnetwork of toll-like receptor-related proteins and their 40 interacting proteins was further analyzed. This analysis showed that these 40 interacting proteins have already been reported to carry almost 1000 nonsynonymous SNPs coding for alternative protein sequences ([Table 3](#t3-jaa-3-177){ref-type="table"}).

Finally, we manually annotated the whole set of 309 proteins in [Figure 1B](#f1-jaa-3-177){ref-type="fig"}. A thorough analysis showed that the most common class of annotations for these proteins was "cytokine--cytokine receptors". We have generated a network of these proteins in [Figure 5](#f5-jaa-3-177){ref-type="fig"} (green proteins) and enlarged the pathway by also including their interacting proteins (yellow proteins, [Figure 5](#f5-jaa-3-177){ref-type="fig"}). A strong input of other chemokines and signal transduction proteins is also seen here.

Discussion
==========

Asthma is a major burden for health care worldwide. Although the pathophysiology of asthma has been studied intensively during recent years, much more work needs to be done before it will be possible to prevent the onset of symptoms of asthma and to cure patients. A great number of genetic analyses have been conducted with asthma patients describing SNPs in the coding sequences of several proteins and intergenic, nontranslated regions close to protein coding sequences. During recent years, more than 100 candidate genes harboring these SNP modifications have been associated with bronchial asthma.

Our aim in the present work was to start a systems level analysis of the putative pathogenetic mechanisms involved in asthma. Databases, and especially their integrated and merged data warehouses, allow rapid and convenient access to the data publicly available. Furthermore, it is possible to integrate one's own data on top of the publicly available data and thus enhance the level of information. In this study, starting with 127 SNP-modified genes converted to the corresponding proteins obtained from published data, we could identify a protein--protein interaction network of over 1000 proteins.

Instead of focusing our analysis only on one or a few altered genes or their corresponding proteins, we attempted to generate larger protein--protein interaction networks from our data. No single database alone can provide such a connected network; in order to understand the new systems levels of diseases, we decided to build up an integrated data warehouse combining information from several databases. We are now able to show how the 127 proteins of asthma patients were connected together in a putative network. One of the most prominent observations in this network was that it was strongly enriched with protein binding, signal transduction, and peptidase functions. The network contained several subnetworks enriched with toll-like receptors or chemokines.

The innate immune system responds to invading pathogens by activating a proinflammatory cascade aiming at eradicating the invading agents. Pattern recognition receptors are a crucial part of this innate immune reaction.[@b19-jaa-3-177] A variety of intra- and extracellular pattern recognition receptors are known today, of which toll-like receptors are involved in the recognition of molecular structures specific for microbial pathogens.[@b20-jaa-3-177] Two main categories of toll-like receptors exist, ie, cell surface receptors and receptors localized in the endosome. It is important to make this distinction because surface toll-like receptors bind molecules on the bacterial cell wall, such as bacterial lipopeptides (TLR2) or lipopolysaccharide (TLR4), whereas endosomal toll-like receptors that are activated by microbial nucleic acids are less readily accessible.[@b21-jaa-3-177]

Research has shown that toll-like receptors can now be divided into two groups on the basis of their subcellular localization. The first group (TLR1, TLR2, TLR4, TLR5, and TLR6) is present on the surface of the cell, and recognizes lipid structures and, in the case of TLR5, the protein flagellin. The second group (TLR3, TLR7, TLR8, and TLR9) resides intracellularly and recognizes nucleic acids. The reason for the different localization of toll-like receptors may be that TLR1, TLR2, TLR4, TLR5, and TLR6 recognize markers on the surface of pathogens, while TLR3, TLR7, TLR8, and TLR9 recognize nucleic acids derived from the genome of viruses and bacteria. It has become increasingly apparent that the localization and traffic of toll-like receptors within the cell is an important mechanism whereby toll-like receptors sense their ligands. Importantly, the traffic of certain toll-like receptors during signaling can also prevent overactivation of the toll-like receptor signaling pathways.[@b22-jaa-3-177]

A small proportion of SNP mutations can cause the altered amino acid sequence in the corresponding protein directly. Genes that have previously been shown to have a SNP mutation leading to a change in the actual protein structure and which have also been linked with asthma, are presented in red in [Figure 4](#f4-jaa-3-177){ref-type="fig"} (TLR1, TLR4, TLR5, TLR6, TLR10, and IL4R and IL13).[@b23-jaa-3-177]--[@b26-jaa-3-177] Genes colored green have been shown to be asthma-related SNPs, but these SNP mutations do not have any effect on protein structures (IL4, STAT6, CD14, RIPK2, TLR2, TLR9). There are altogether 54 protein coding genes in the same pathway, with the aforementioned asthma-related genes having a SNP mutation ([Figure 4](#f4-jaa-3-177){ref-type="fig"}).

The aberrant activation of toll-like receptor pathways, on the other hand, has been implicated in various chronic and autoimmune diseases affecting the gastrointestinal tract, central nervous system, kidneys, skin, lungs, and joints, whereby both exogenous and endogenous ligands have been suggested to act as toll-like receptor activators. The finding that intracellular proteins or the products of protein cleavage can act as endogenous ligands for toll-like receptors supports the hypothesis that toll-like receptors are important in mediating the response not only to infections but also to stress, damage, and death of cells in general.[@b27-jaa-3-177]

New developments in the fields of allergy and immunology have yielded a variety of novel therapeutic approaches in recent years, resulting in more agents at the clinical trial stage as well. Among the therapeutic approaches are the toll-like receptor agonists, immunostimulatory oligodeoxynucleotides, oral and parenteral cytokine blockers, and specific cytokine receptor antagonists. However, a much better understanding of the "big picture of this systems inflammatory disease" must still be obtained before more target therapeutic approaches can be designed.[@b28-jaa-3-177]

Compared with the latest reports in which only one gene at a time has been in focus when analyzing the pathogenetic mechanisms of multifactorial diseases like asthma, we have now focused on the entire set of 127 genes and their corresponding proteins. Of these 127 genes, 96 could be connected to a same gene-mRNA-protein and protein--protein interaction network, and were found to be enriched significantly with protein binding, signal transduction, and endopeptidase activities. Taken together, we showed in this study using our in silico analysis framework and the outside databases that we can increase the level of knowledge by performing systems level analyses of previously characterized genes carrying SNPs related to asthma.
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![**A**) The protein--protein binding network is built on the basis on two sources of data, ie, the asthma pathogenesis literature published on the putative association of single nucleotide polymorphisms within genes coding corresponding proteins and the protein--protein interaction network data for all these proteins. The original dataset from the literature with 127 genes with single nucleotide polymorphism modifications were converted to corresponding proteins (synonymous marked as green and nonsynonymous marked as red nodes). The interacting protein partners for each of these proteins (yellow nodes) were searched using protein interaction network analysis. **B**) The [Figure 1A](#f1-jaa-3-177){ref-type="fig"} network was modified so that each interacting protein (yellow nodes) binds to at least two (synonymous marked as green and nonsynonymous marked as red nodes) single nucleotide polymorphism proteins. A Cytoscape file can be loaded from the online supporting information. All the proteins are marked with the SwissProt name, but without the tag "\_HUMAN" for clarity (see [Table 1](#t1-jaa-3-177){ref-type="table"}).](jaa-3-177f1){#f1-jaa-3-177}

![Sixty-five asthma-related single nucleotide polymorphism proteins showed interconnectivity; 14 interact with themselves, 20 form a pair, two triplets, one a quartet, and two larger networks contain several connected asthma-related single nucleotide polymorphism proteins. The chemokine network includes eight proteins and the toll-like receptor network 13 proteins which are all shown to carry asthma-related single nucleotide polymorphism modifications among their corresponding genes. Synonymous nodes are marked as green and nonsynonymous nodes are marked as red.](jaa-3-177f2){#f2-jaa-3-177}

![The chemokine network shows eight asthma-related single nucleotide polymorphism proteins (green nodes) binding to each other and their receptors (yellow nodes) found in the integrated protein interaction network analysis database.](jaa-3-177f3){#f3-jaa-3-177}

![The toll-like receptor network displays 13 asthma-related single nucleotide polymorphism proteins (synonymous marked as green and nonsynonymous marked as red nodes) interacting with each other and their receptors (yellow nodes). The red nodes represent proteins TLR1, TLR4, TLR5, TLR6, TLR10, and IL4R and IL13, which are the nonsynonymous single nucleotide polymorphisms coding for an alternative amino acid sequence of proteins.](jaa-3-177f4){#f4-jaa-3-177}

![After manually annotating the whole set of 309 proteins in [Figure 1B](#f1-jaa-3-177){ref-type="fig"} we realized that the most common class of annotations for these proteins was "cytokine--cytokine receptors". The cytokine--cytokine receptors network was created by using these selected single nucleotide polymorphism proteins (synonymous marked as green nodes and nonsynonymous marked as red nodes) and further enlarged by also including their interacting proteins (yellow nodes).](jaa-3-177f5){#f5-jaa-3-177}

###### 

A list of 127 genes and their corresponding proteins, where SNP(s) have been found to relate to allergic diseases

  **GENE**       **PROTEIN**   **PMID**   **ALOX5AP**   **AL5AP**   **18547289**   **TGFB1**    **TGFB1**   **17333284**
  -------------- ------------- ---------- ------------- ----------- -------------- ------------ ----------- --------------
  ARG1           ARGI1         19281908   **LTA4H**     **LKHA4**   18547289       IL27         IL27A       17318299
  **ARG2**       **ARGI2**     19281908   **CTTN**      **SRC8**    18521921       **MYLK**     **MYLK**    17266121
  **IL10**       **IL10**      19222424   **PTGS2**     **PGH2**    18489027       **CD40**     **TNR5**    17255560
  **PPARG**      **PPARG**     19217272   **PTPRD**     **PTPRD**   18414509       **CCL11**    **CCL11**   17220216
  **IL1RL1**     **ILRL1**     19198610   CRHR2         CRFR2       18408560       CYSLTR1      CLTR1       17154652
  WDR36          WDR36         19198610   CHI3L1        CH3L1       18403759       CYSLTR2      CLTR2       17154652
  **IL33**       **IL33**      19198610   **IL4**       **IL4**     18396027       **CCR5**     **CCR5**    17154652
  **MYB**        **MYB**       19198610   IFNG          IFNG        18385742       **SOCS1**    **SOCS1**   17099141
  CTNNA3         CTNA3         19187332   **IL18R1**    **IL18R**   18382474       **IL9R**     **IL9R**    17083349
  **TLR2**       **TLR2**      19148143   **GSTP1**     **GSTP1**   18335111       **RIPK2**    **RIPK2**   17075290
  **ADAM33**     **ADA33**     19146844   **TLR9**      **TLR9**    18312481       **CHRM1**    **ACM1**    16931638
  **CD14**       **CD14**      19096003   NPSR1         B7ZMA2      18305139       **IL7R**     **IL7RA**   16890764
  HLX1           HLX           19038437   **TNC**       **TENA**    18305139       **LIFR**     **LIFR**    16890764
  **TNF**        **TNFA**      19004142   **NPPA**      **ANF**     18294255       **AOAH**     **AOAH**    16815140
  **GSTM1**      **GSTM1**     18988661   **IL18**      **IL18**    18200581       **PDGFRA**   **PGFRA**   16804324
  **CMA1**       **CMA1**      18973102   **INPP4A**    **INP4A**   18187694       NPS          NPS         16790440
  **CXCR3**      **CXCR3**     18962861   UGRP1         SG3A2       18089940       SFRS8        SFRS8       16738036
  CRTH2          GPR44         18946232   **CCR3**      **CCR3**    17983872       MMP-9        MMP-9       16631427
  **IL6**        **IL6**       18810365   **IL5RA**     **IL5RA**   17983872       **ICAM1**    **ICAM1**   16625213
  **IL1RN**      **IL1RA**     18810365   **FCER2**     **FCER2**   17980418       MBL2         MBL2        16487239
  IL21           IL21          18802358   **EDN1**      **EDN1**    17960156       **DEFB1**    **DEFB1**   16435024
  IL1B           IL1B          18773331   TBX21         TBX21       17949803       **IL16**     **IL16**    16387589
  **MYLK**       **MYLK**      18766098   PTGER3        PE2R3       17877755       **ALOX5**    **LOX5**    16361798
  ORMDL3         ORML3         18754760   **HLA-G**     **HLAG**    17847008       **C3**       **CO3**     16355111
  **ACE**        **ACE**       18727619   PHF11         PHF11       17702965       **TLR4**     **TLR4**    16215326
  **CYBA**       **CY24A**     18716406   TGF-beta1     TGFB1       17673695       **DPP10**    **DPP10**   15986064
  **SERPINE1**   **PAI1**      18714537   **KAT5**      **KAT5**    17672871       LTA          TNFB        15969671
  CCL24          CCL24         18712274   GCLC          GSH1        17643973       **GATA3**    **GATA3**   15637551
  **CCL26**      **CCL26**     18712274   **HAVCR1**    **TIMD1**   17570927       CLCA1        CLCA1       15318163
  **CCL17**      **CCL17**     18691306   **ITGB3**     **ITB3**    17556058       **TLR10**    **TLR10**   15201134
  **MS4A2**      **FCERB**     18691306   ADH5          ADHX        17543375       **DAP3**     **RT29**    15179560
  **IL13**       **IL13**      18691306   **PTGDR**     **PD2R**    17538632       **IL15**     **IL15**    15131572
  **IL4R**       **IL4RA**     18691306   **STAT4**     **STAT4**   17532201       **NOS1**     **NOS1**    14767694
  **TLR7**       **TLR7**      18682521   **STAT6**     **STAT6**   17519224       **TAP1**     **TAP1**    12640628
  **TLR8**       **TLR8**      18682521   PTGER2        PE2R2       17496729       **CTLA4**    **CTLA4**   12417883
  **GRK5**       **GRK5**      18622265   PTGER4        PE2R4       17496729       AICDA        AICDA       11544457
  CHIA           CHIA          18602573   **PTGIR**     **PI2R**    17496729       **CCL2**     **CCL2**    11544456
  **FCER1G**     **FCERG**     18595682   **TBXA2R**    **TA2R**    17496729       **IKBKAP**   **ELP1**    11281413
  **FCER1A**     **FCERA**     18595682   **TNF**       **TNFA**    17450233       **C5**       **CO5**     10973279
  **ADRB2**      **ADRB2**     18558635   **SFTPA2**    **SFPA2**   17407567       **CCL5**     **CCL5**    11197694
  **TLR1**       **TLR1**      18547625   **PLAU**      **UROK**    17363771       **LTC4S**    **LTC4S**   10970818
  **TLR6**       **TLR6**      18547625   RNASE3        ECP         17362255                                

**Notes:** The proteins displayed on the common pathway as shown in [Figure 2](#f2-jaa-3-177){ref-type="fig"} are marked in bold. The SwissProt names for proteins are used without the tag \_HUMAN throughout the study.

###### 

Gene ontology (GO) enrichment on the SNP-related proteins and their first binding partners

  **GO-ID**   ***P*-value**   **x**   **nX**   **Description**
  ----------- --------------- ------- -------- --------------------------------------
  5515        6.5707E-69      256     7023     Protein binding
  4871        4.9020E-44      130     2217     Signal transducer activity
  6950        8.1435E-63      120     1258     Response to stress
  19538       2.1909E-15      98      2768     Protein metabolic process
  4872        2.9275E-20      84      1792     Receptor activity
  5102        3.3451E-40      77      765      Receptor binding
  166         3.8108E-3       50      2146     Nucleotide binding
  43234       8.1977E-5       48      1712     Protein complex
  7267        3.5518E-16      40      535      Cell--cell signaling
  5509        1.1569E-8       40      932      Calcium ion binding
  16740       7.7375E-3       40      1693     Transferase activity
  30528       5.7626E-3       35      1405     Transcription regulator activity
  16265       2.2804E-12      33      485      Death
  8219        2.2804E-12      33      485      Cell death
  16301       4.3301E-7       33      788      Kinase activity
  30154       6.4206E-5       33      1001     Cell differentiation
  50222       4.2327E-9       31      580      Protein kinase activity
  8233        6.9718E-7       28      616      Peptidase activity
  16023       3.4546E-7       21      359      Cytoplasmic membrane-bounded vesicle
  6629        1.1188E-2       20      716      Lipid metabolic process
  5768        2.8622E-8       18      228      Endosome
  8283        1.8276E-5       16      290      Cell proliferation
  8092        1.0819E-2       14      437      Cytoskeletal protein binding
  30246       8.7209E-4       13      292      Carbohydrate binding
  8289        8.3026E-3       13      380      Mol funct lipid binding
  9719        5.2362E-6       11      125      Response to endogenous stimulus
  3779        2.5076E-2       10      305      Actin binding
  16032       3.2732E-5       7       57       Viral reproduction

**Notes:** Go-ID is the GO class, x represents of the number of observed proteins in our data set, nX is the number of proteins in the background comparison dataset.

###### 

Forty interacting proteins from the toll-like receptor-pathway ([Figure 4](#f4-jaa-3-177){ref-type="fig"}), which have been reported to carry altogether almost 1000 nonsynonymous single nucleotide polymorphisms coding for alternative protein sequences

  **Gene**   **SNP**      **Type**                                      **PMID**
  ---------- ------------ --------------------------------------------- --------------------
  TLR1       rs5743594    intronic                                      18547625
             rs5743595    Intronic                                      18547625
             rs4833095    nonsynonymous-coding                          18547625
  TLR2       rs4696480    intronic                                      18547625
             rsl898830    intronic                                      18547625
             rs3804099    synonymous-coding                             18547625
             rs2289318    upstream                                      19096003
  TLR3       rs3775291    nonsynonymous-coding                          18547625
  TLR4       rs2737190    upstream                                      18547625
             rsl0759932   upstream                                      18547625
             rs4986791    nonsynonymous-coding                          18547625
             rsll536889   downstream/3prime utr                         19096003
             rs7045953    upstream                                      19096003
  TLR5       rs5744168    stop gained                                   18547625
             rs2072493    nonsynonymous-coding                          18547625
             rs5744174    nonsynonymous-coding                          18547625
  TLR6       rs5743789    upsream/intronic                              18547625
             rs5743819    nonsynonymous-coding                          18547625
  TLR7       rsl79008     nonsynonymous-coding                          18547625, 18682521
  TLR8       rs3761624    upstream                                      18547625
             rs2407992    synonymous-coding                             18682521
  TLR9       rsl87084     upstream                                      18547625, 19247692
             rs5743836    upstream                                      18547625
             rs352143     upstream                                      19096003
             rs352163     upstream                                      19096003
             rs353547     downstream                                    19096003
  TLR10      rsll096956   synonymous-coding                             18547625
             rs4129009    nonsynonymous-coding                          18547625
             rsll09657    nonsynonymous-coding                          19247692
  IL13       rsl881457    within_non_coding_gene/upsteam                19796199
             rsl800925    within_non_coding_gene/upsteam                19796199
             rs2243204    downstream                                    19247692
             rsl295686    within noncoding gene/intronic                19247692
             rs20541      nonsynonymous-coding/within_non_coding_gene   19254294
  IL4        rs2243250    upstream                                      18263811
  IL4RA      rsl805010    non_synonymous_coding/downstream              19796199
  STAT6      rs324015     3prime-utr                                    19247692
             rs324011     intronic                                      19247692
  RIPK2      rs2293807    downstream                                    17075290
  CD14       rs2569190    3prime_utr/intronic                           18925877
